KIDNEY TRANSPLANT; COMPLICATIONS

This study tests whether a 12-week home-based exercise program can improve heart health in kidney transplant recipients. Half of the 50 participants will follow the exercise plan, while the other half continues usual care. Researchers will use detailed MRI scans to measure change…

This study was designed to see if taking sodium bicarbonate (a common antacid) could reduce the risk of harmful calcium buildup in the blood vessels of kidney transplant recipients. It planned to give participants either a low or high dose of sodium bicarbonate and measure change…

This study aimed to see if a special blood filter (Seraph 100) could reduce BK virus levels in kidney transplant patients with high viral loads. It planned to enroll adults with a BK virus level of 10,000 IU/mL or higher who already had dialysis access. However, the trial was wit…

This study looks at two versions of the drug tacrolimus, which is used to prevent organ rejection after a kidney transplant. One version is taken once a day, the other twice a day. The goal is to see which one does a better job at keeping blood vessels healthy, measured by how st…

This study tests whether teaching kidney transplant recipients to eat a whole-food plant-based diet can improve their blood pressure, blood sugar, and weight, and reduce hospital visits and infections. About 49 adults who had a kidney transplant in the past 2–12 months and have h…

This study tests whether a newer drug, letermovir, works better and causes fewer side effects than the standard drug valganciclovir for preventing CMV infection in African American kidney transplant recipients. About 30 high-risk patients will take letermovir for 6 months after t…

This study compares robot-assisted kidney transplant to the standard open surgery in 106 adults with end-stage kidney disease. The goal is to see if the robotic approach reduces serious complications like bleeding or blood clots within 30 days after surgery. Participants are rand…

This study tests whether a bone marrow transplant, given after a kidney transplant, can help the body accept the new kidney without needing lifelong anti-rejection drugs. About 20 adults aged 18-65 who already have a well-functioning kidney transplant will receive an investigatio…

This study tests whether a short course of two drugs (glecaprevir/pibrentasvir and ezetimibe) can prevent hepatitis C infection in people who receive a kidney, heart, lung, or pancreas from a donor with hepatitis C. About 200 participants who are hepatitis C-negative will take th…

This study looks at whether measuring a specific type of immune cell (called highly suppressive Treg) before a kidney transplant can predict if the new kidney will work slowly or need dialysis. Researchers will test blood samples from 180 adult kidney transplant candidates. The g…